MacroGenics
MGNX
85 hedge funds and large institutions have $322M invested in MacroGenics in 2014 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 36 increasing their positions, 24 reducing their positions, and 10 closing their positions.
50% more repeat investments, than reductions
Existing positions increased: 36 | Existing positions reduced: 24
3% more capital invested
Capital invested by funds: $313M → $322M (+$8.86M)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
4% less funds holding
Funds holding: 89 → 85 (-4)
40% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 10
95% less call options, than puts
Call options by funds: $2K | Put options by funds: $42K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BRC
Blue Ridge Capital
New York
|
+$9.31M |
| 2 |
Bank of America
Charlotte,
North Carolina
|
+$4.92M |
| 3 |
EAM
EverPoint Asset Management
Stamford,
Connecticut
|
+$3.93M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$3.68M |
| 5 |
Northern Trust
Chicago,
Illinois
|
+$2.35M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Point72 Asset Management
Stamford,
Connecticut
|
-$10.3M |
| 2 |
PA
Perceptive Advisors
New York
|
-$4.51M |
| 3 |
PC
PointState Capital
New York
|
-$4.14M |
| 4 |
SM
Sabby Management
Miami Beach,
Florida
|
-$3.26M |
| 5 |
BIM
Bogle Investment Management
Newton Lower Falls,
Massachusetts
|
-$3.12M |
MGNX Hedge Fund Activity: Q3 2014 in Review
85 of the 3,446 institutional investors tracked by Wall St. Rank reported a position in MacroGenics (MGNX) for Q3 2014, worth a combined $322M — up 2.8% from $313M a quarter earlier.
Sellers outnumbered buyers: 10 funds closed out of MGNX and 6 opened new positions — a net loss of 4 holders — while 24 trimmed existing stakes and 36 added.
The largest buyer was Blue Ridge Capital, adding an estimated $9.31M. The largest seller was Point72 Asset Management, cutting an estimated $10.3M.
- 85 institutional investors held MacroGenics (MGNX) as of Q3 2014, down from 89 in Q2 2014.
- Funds reported $322M of MacroGenics stock for Q3 2014, up 2.8% quarter-over-quarter.
- 6 funds opened new MacroGenics positions in Q3 2014 and 10 closed out, a net change of -4 holders.
- The largest MacroGenics buyer in Q3 2014 was Blue Ridge Capital, an estimated $9.31M added.
- The largest MacroGenics seller in Q3 2014 was Point72 Asset Management, an estimated $10.3M sold.
Based on aggregated 13F filings for Q3 2014.